Anders Clausen as Deep Branch’s new Chief Innovation Officer.
Anders will oversee the company’s technical leadership team in setting and executing its research and development strategy and ensuring Deep Branch holds robust intellectual property for its technology platform and products. He will also lead in establishing external research and development collaborations for the business.
He joins the company after founding Productus, a business dedicated to providing guidance on research and development strategy and production process development within bioscience. Prior to this, Anders spent over a decade with cultures and probiotics producer Chr. Hansen, primarily focusing on developing new products and production platform technologies for stabilising lactic acid bacteria as starter cultures and probiotics.
“The microbial protein sector is still in its infancy. However, it’s clear that Deep Branch will play a crucial role in shaping its maturity. We’re ideally placed to define the opportunities for single-cell protein globally and unlock the potential of gas fermentation by solving the remaining technical and engineering challenges,” Anders said.
“Joining Deep Branch on this journey is incredibly exciting given the scientific and commercial opportunities it represents,” Anders added.
“Commercialising any technology is about more than good ideas – it requires strong execution. This is crucial in biotechnology because our development cycles are so long compared to other industries. Anders brings a wealth of experience in managing the commercialisation of new bioprocesses through their full innovation life-cycle,” Deep Branch’s CEO Pete Rowe said.
“Anders will be integral in bringing our (R)evolve™ gas fermentation platform to full maturity, ensuring we can commercialise products quickly, efficiently and with the ability to meet genuine market demand,” Rowe added.